Previous 10 | Next 10 |
Marine Petroleum Trust (MARPS) -43%.Barnwell Industries (BRN) -39%.Tengasco (TGC) -32%.PEDEVCO (PED) -34%.New Concept Energy (GBR) -30% pared yesterday's gains following latest Reddit craze.Ucommune International (UK) -28% after pricing share and warrant offering.Hous...
Adamis Pharmaceuticals (ADMP) slumped 10.7% lower in after hours trade after planning to sell shares in an underwritten public offering.Underwriters granted 30-day option to purchase up to an additional 15% of shares.Offer size, terms have not yet been disclosed. For further ...
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) in collaboration with the Human Immune Monitoring Center at Stanford University have conducted a study to investigate the effects of Tempol on immune cells from CO...
Adamis Pharmaceuticals (ADMP) announces that it has entered into a non-binding letter of intent with a potential buyer for the sale of its US Compounding unit.Under the terms in the letter of intent, the buyer would agree to acquire substantially all of the assets of US Compounding ...
SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has entered into a non-binding letter of intent with a potential buyer for sale of substantially all of the assets of its US Compounding Inc. (USC) subsidiary. Unde...
Repro Med Systems (KRMD) -18% on preliminary FY20 results and CEO transition.Sanchez Midstream Partners (SNMP) -17%.Express (EXPR) -16% as Wedbush sees company 'hemorrhaging cash'.Lipocine (LPCN) -14% on launch of public offering.Midatech Pharma (MTP) -10%...
Palm Beach, FL – January 25, 2021 Ovarian cancer is one of the most deadly gynecologic malignancy across the globe, but new treatments are gaining increased efficacy while displaying reduced toxicity. Clinical trials abound. Immunotherapy using immune-checkpoint modulators has been r...
Adamis Pharmaceuticals finished 2020 with some Malheur with the company receiving its second CRL for ZIMHI. However, the company is a making a strong comeback thus far in 2021. Adamis plans to appeal the FDA decision on ZIMHI and has requested a Type A meeting. If all goes well,...
Gainers: AzurRx BioPharma (AZRX) +59%.Climate Change Crisis Real Impact I Acquisition (CLII) +59%.GameStop (GME) +55%.Adamis Pharmaceuticals (ADMP) +41%.111 (YI) +41%.Asia Pacific Wire & Cable (APWC) +37%.Polar Power (POLA) +35%.Electro-Sensors (ELSE) +31%.Mmtec (MTC) +28%.MingZ...
Gainers: Adamis Pharmaceuticals (ADMP) +47%, AzurRx BioPharma (AZRX) +38%, 111 (YI) +27%, Obalon Therapeutics (OBLN) +17%, iBio (IBIO) +17%.Losers: Celsion CLSN -18%, ViewRay VRAY -14%, ADiTx Therapeutics (ADTX) -14%, Passage Bio PASG ...
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...